Octagon Capital Advisors’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-325,050	Closed	-$3.05M	–	44
2023 Q3	$3.05M	Sell	325,050 -325,050	-50%	-$3.05M	0.47%	30
2023 Q2	$15.9M	Buy	+650,100	New	+$15.9M	2.22%	12